DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo


53.33 -0.06 (-0.11%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

TSRO $53.33 -0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $53.54
Previous Close $53.39
Daily Range $52.09 - $54.26
52-Week Range $22.15 - $54.26
Market Cap $1.9B
P/E Ratio -11.15
Dividend (Yield) $0.00 (0.0%)
Volume 399,983
Average Daily Volume 391,128
Current FY EPS -$5.10




Drug Makers

TESARO (TSRO) Description

TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. Website:

News & Commentary

What Was Behind Tesaro Inc.'s 21% Pop?

Tesaro and Opko's rolapitant successfully achieved primary and secondary endpoints in reducing chemotherapy-induced nausea and vomiting.

Jeff Cooper: How Big Is The Next Trend Turn?

If the market melts up from here, the cycles suggest a possible melt-down.

TESARO (TSRO) is in Overbought Territory: What's Next? - Tale of the Tape

Citigroup Adds Tesaro To 'Focus List,' Removes Medivation

TESARO's (TSRO) CEO Lonnie Moulder on Q4 2014 Results - Earnings Call Transcript

Investing In Precision Oncology: Targeting NTRK Genomic Alterations

Insiders Were Right: TSRO Makes New 52-Week High

Interesting TSRO Put And Call Options For February 20th

TSRO: Insiders Vs. Shorts

Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog

TESARO's (TSRO) CEO Lonnie Moulder on Q3 2014 Results - Earnings Call Transcript

See More TSRO News...